Immunosuppressant therapy averts rejection of allogeneic FKBP1A-disrupted CAR-T cells

Colby R. Maldini(Beam Therapeutics (United States)), Todd M. Allen(Ragon Institute of MGH, MIT and Harvard)
Molecular Therapy
September 1, 2024
Cited by 12


Related Papers